Therapy Insight: bladder dysfunction associated with multiple sclerosis
- 1 October 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Endocrinology
- Vol. 2 (10) , 492-501
- https://doi.org/10.1038/ncpuro0323
Abstract
Bladder dysfunction is a common problem for patients with multiple sclerosis. The severity of symptoms often correlate with the degree of spinal cord involvement and, hence, the patient's general level of disability. The emphasis of management is now mainly medical and is increasingly offered by nonurologists. Treatments can be highly effective, relieving patients of what are otherwise very troublesome symptoms that would compound their neurological disability. This article gives an overview of the neural control of the bladder, followed by an explanation of the pathophysiology of detrusor overactivity secondary to neurological disease. A review of methods available for treating bladder dysfunction in multiple sclerosis then follows. The treatment options for this disorder are largely medical and include established first-line measures such as anticholinergics, clean intermittent self-catheterization and the use of desmopressin, as well as potential second-line agents, such as cannabinoids, intravesical vanilloids and intradetrusor botulinum neurotoxin type A. The diminishing role of surgical intervention is also discussed.Keywords
This publication has 68 references indexed in Scilit:
- Prevalence of conditions potentially associated with lower urinary tract symptoms in menBJU International, 2005
- Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan‐neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatmentBJU International, 2004
- Intravesical Capsaicin Versus Resiniferatoxin for the Treatment of Detrusor Hyperreflexia in Spinal Cord Injured Patients:: A Double-Blind, Randomized, Controlled StudyJournal of Urology, 2004
- Reduced quality of life among multiple sclerosis patients with sexual disturbance and bladder dysfunctionMultiple Sclerosis Journal, 2001
- Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous SystemThe Journal of Clinical Pharmacology, 2001
- TolterodineDrugs & Aging, 2001
- Euphorbium: Modern research on its active principle, resiniferatoxin, revives an ancient medicinePublished by Elsevier ,1998
- Investigation of the neurogenic bladder.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Intravesical capsaicin for neurogenic bladder dysfunctionThe Lancet, 1992
- Mechanisms underlying the recovery of urinary bladder function following spinal cord injuryJournal of the Autonomic Nervous System, 1990